Member Info for BeepBoop

It means they need to punch through the area around the wellbore (which will have been damaged and compressed by the drilling of the well) and generate fractures in the rock that connect to the natural helium bearing fractures. The goal, as I understand, is to improve flow by connecting to undamaged reservoir. The fact that the formation is taking fluids and showing pressure responses is a good sign.

Ah thanks, got confused which thread I'd posted on

;)

Hoping for a good RNS next week. GLA

Umm where did my post go? It's vanished but I didn't break any forum rules. Very strange.

Looks like msuk's had an integer overflow.

But, Wallace, they've been running the test for over a month, and they have preliminary analysis of the HELIUM GAS, so there is gas flowing, i.e. it's not a duster. They also use the words "completion" and "development", which they would not do if there was no commercial potential. How much work is needed to make the reservoir commercial, and whether that will include drilling beyond this particular well, remains to be seen, but there is ample explicit evidence in the wording of the tweet that this is not a duster.

Cev, wasn't me who complained. Somebody beat me to it. LSE can't leave libel up, which that post certainly was. Agreed -- TWK is the most obnoxious poster I've yet encountered on LSE. I think it's intentional though to anger people into engaging with his posts, so I ignore him.

Chromo was replying to TWK's now deleted post accusing Roughan of sharing market sensitive info, which he hasn't done, because DH already RNS'd that they were in the late stages of contract finalisation.

Agreed. Bit annoyed they said the oil & gas revenue would fund the helium projects and then went and did a placing, but encouraged by the institutional support. Was planning on topping up today and have done so. Didn't think I'd be getting new shares close to my original entry price! Feels like a bargain.

It's a UK govt website that has the countdown. It might just be that they open to proposals tonight though, no funding announcements, in which case we will have longer to wait to find out if DH gets a slice of the pie.

When/if this stock re-rates I do not think it will be gradual.

Https://www.sovereignai.gov.uk

Click SOV/AI top left and scroll down. The countdown timer is second from bottom.

The sovereign AI fund doesn't launch until 18:00 GMT on April 16, so I doubt we'll get an RNS that day. The RNS (if it comes) will be the 17th or the following week. If there is an RNS with a contract or funding I think the SP will go to 6p or above. If no RNS by next week it will start sinking toward 1p again. No idea what it will be end of 26.

Is there any chance IMM have been required to complete a fundraising round as a condition of a deal? I see something like that going on over at Roquefort Therapeutics this morning. Not an expert in the pharma space so maybe someone with more relevant knowledge can comment.

6 months is a reasonable time frame for publishing a paper. It can take as little as 3-4 months, but usually longer. (I'm scientist.) I don't know what stage they are at with the paper but I wouldn't be surprised if it takes as long as or longer than the deal.

Funny you should say that halfbutt, I was thinking earlier today that I have the same feeling. In my case I trace it to Tim's statement that IMM "live and die by our news flow, and don't we know it". Suggests they may feel pressure to RNS more often. I'm sure there are things we haven't been told, so I expect surprises.

Thanks Prof, that's really interesting. Nice to see that kapiglucagon fits under the "immune" branding of IMM.

In any case, developing a second drug, which they are now funded to do, actually decreases risk because now not everything is riding on P140. It also makes sense for them to go for it now and get that program going while waiting for the lengthy discussions re: P140 to play out.

Hamila -- yes exactly, that's the vibe I got too -"of course P140 works, don't ask such dumb questions"!

GLA genuine investors!

Me too hamila! For me his "No" was the most convincing part of this whole presentation. It really sounds like the science is solid and they are waiting on potential partners to do due diligence.

He's French Canadian, not Italian. But yeah, he seemed to be throwing his hands up as if he doesn't know what to say, and I don't know whether that's because he thinks shareholders don't understand the process of R&D and the negative reaction to the RNS is OTT, or for some more negative reason (in terms of company outlook).

Personally I'm out for now -- dumped my shares shortly after open on March 17 because I don't want to sit on a large paper loss. MAY buy back in but will be very cautious about it.

She is head of investor relations so it's part of her job to communicate with investors, who are sending her messages because they are anxious due to the news vacuum.

Switch brokers. T212 is absolute crap. Orders go through instantly on IG and you get a quote so you know exactly what you will be paying before you confirm the purchase.